# Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury

> **NCT06394284** · PHASE3 · RECRUITING · sponsor: **Herzog Hospital** · enrollment: 60 (estimated)

## Conditions studied

- PTSD, Post Traumatic Stress Disorder
- Moral Injury

## Interventions

- **DRUG:** MDMA-AT
- **BEHAVIORAL:** SEA-IT

## Key facts

- **NCT ID:** NCT06394284
- **Lead sponsor:** Herzog Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-18
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06394284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06394284, "Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06394284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*